Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials.
about
Thrombolysis for acute ischaemic strokeReview, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptomsThe exact science of stroke thrombolysis and the quiet art of patient selectionFinal infarct volume discriminates outcome in mild strokesNinety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke.Magnetic Resonance Imaging in Acute Ischemic Stroke Patients with Mild Symptoms: An Opportunity to Standardize Intravenous ThrombolysisEndovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional NeurologyIntravenous thrombolysis for acute ischemic stroke patients presenting with mild symptoms.Safety and outcome of thrombolysis in mild stroke: a meta-analysis.The outcome of patients with mild stroke improves after treatment with systemic thrombolysis.Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke.To treat or not to treat? Pilot survey for minor and rapidly improving stroke.Defining mild stroke: outcomes analysis of treated and untreated mild stroke patients.Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms.Mild stroke and rapidly improving symptoms: it's not always a happy ending.How common is isolated dysphasia among patients with stroke treated with intravenous thrombolysis, and what is their outcome? Results from the SITS-ISTR.Variability in the use of intravenous thrombolysis for mild stroke: experience across the SPOTRIAS networkLower NIH stroke scale scores are required to accurately predict a good prognosis in posterior circulation strokeIntravenous thrombolysis for minor stroke and rapidly improving symptoms: a quantitative overview.Door-to-Needle Delays in Minor Stroke: A Causal Inference Approach.One-year outcomes and secondary prevention in patients after acute minor stroke: results from the China National Stroke Registry.Itemized NIHSS subsets predict positive MRI strokes in patients with mild deficits.Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of 'minor stroke'.Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel.Visual field defect after ischemic stroke-impact on mortality.Do lacunar strokes benefit from thrombolysis? Evidence from the Registry of the Canadian Stroke Network.Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis.DWI Reversal Is Associated with Small Infarct Volume in Patients with TIA and Minor Stroke
P2860
Q24194788-590E4769-F6EF-4C06-AD02-AB64630D4E25Q26825583-D42E1E61-D81C-4423-A099-65E7382D38F6Q27011873-0D6EA7C5-570A-4C76-9367-6C4976AF363AQ30357410-4E5C2EF2-C569-4A39-836F-D30F6D971202Q30422705-DE3CBB45-D669-44E7-BCB9-5ED6AD66AF37Q30956240-76FBCF20-AF05-462C-8164-BEBC64B415A1Q33735191-10941E7A-0507-413A-945D-5D3230446A26Q34262372-7BE24F4E-C8E8-40AF-97E4-966C7B71F97CQ34496025-C11D4F32-C4D8-4A6C-972F-A4886E8CE44FQ34635173-FFBE383B-50CE-405C-89CC-423129481AD1Q35088083-B2777675-4E0F-43E5-AB7A-4355F87FCCD1Q35125986-B99F92B6-9E9D-4965-926D-65268E47FD3AQ35688825-855E138D-B446-43E0-B90F-8E8F7F9D1E0CQ35812842-2F8AABA7-8B53-4F9D-9C82-72982DA56DDAQ36136065-E6BAA7CC-9910-4DA3-BD7A-FF21F8C25047Q36329219-622C6629-CBE1-40D0-8F6E-25DBAC8FB957Q36342027-02FC995C-9E05-44C4-AB51-B9F43280AF01Q37115976-ED7EB7F3-2FAF-4D23-9E24-B455912AD851Q38234091-A12EC31A-6407-4306-A373-EE7D0AE6A606Q38768315-3F4FABEA-87D1-4A7E-8535-F250E1280C56Q38801855-3AFF3689-E334-4CA1-A6E2-CDE835C2978DQ40534364-168013BE-5AA4-46AA-8393-79B90A44FA52Q43453947-DEF5A337-A7EB-4FA1-88BC-F93EA52F01C2Q44143648-239B5931-DE54-4A18-802D-F61238A7ECAFQ47214413-FE9650CD-33EB-4A50-A820-2BADE170957AQ48257270-5FD526D5-40BD-46A8-A903-0BC87FC9AD0AQ52620337-5F428381-03FD-45D6-BFB9-22B1282D7796Q58209271-30F46B18-BEF9-4CFA-B29C-CBAFC45B169B
P2860
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Strokes with minor symptoms: a ...... plasminogen activator trials.
@ast
Strokes with minor symptoms: a ...... plasminogen activator trials.
@en
Strokes with minor symptoms: a ...... plasminogen activator trials.
@nl
type
label
Strokes with minor symptoms: a ...... plasminogen activator trials.
@ast
Strokes with minor symptoms: a ...... plasminogen activator trials.
@en
Strokes with minor symptoms: a ...... plasminogen activator trials.
@nl
prefLabel
Strokes with minor symptoms: a ...... plasminogen activator trials.
@ast
Strokes with minor symptoms: a ...... plasminogen activator trials.
@en
Strokes with minor symptoms: a ...... plasminogen activator trials.
@nl
P2093
P2860
P1433
P1476
Strokes with minor symptoms: a ...... plasminogen activator trials.
@en
P2093
Charles J Moomaw
Dawn O Kleindorfer
Edward C Jauch
Jeffrey L Saver
Joseph P Broderick
Patrick D Lyden
Pooja Khatri
Sharon D Yeatts
Steven R Levine
Yuko Y Palesch
P2860
P304
P356
10.1161/STROKEAHA.110.593632
P407
P577
2010-09-02T00:00:00Z